These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9209907)

  • 21. Topotecan in the treatment of non-small cell lung cancer.
    Perez-Soler R
    Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-34-S20-41. PubMed ID: 9425959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Afatinib: a second-generation EGF receptor and ErbB tyrosine kinase inhibitor for the treatment of advanced non-small-cell lung cancer.
    Marquez-Medina D; Popat S
    Future Oncol; 2015 Sep; 11(18):2525-40. PubMed ID: 26314834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in chemotherapy of non-small cell lung cancer.
    Molina JR; Adjei AA; Jett JR
    Chest; 2006 Oct; 130(4):1211-9. PubMed ID: 17035458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy for advanced non-small cell lung cancer.
    Manegold C
    Semin Oncol; 2001 Apr; 28(2 Suppl 7):1-6. PubMed ID: 11372044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polychemotherapy in advanced non-small-cell lung cancer.
    Rodger A
    Lancet; 1993 Sep; 342(8873):740-1; author reply 741-2. PubMed ID: 8103839
    [No Abstract]   [Full Text] [Related]  

  • 26. Onartuzumab ineffective in non-small-cell lung cancer.
    Brower V
    Lancet Oncol; 2017 Feb; 18(2):e66. PubMed ID: 28017663
    [No Abstract]   [Full Text] [Related]  

  • 27. Missing patient-reported outcome data in an adjuvant lung cancer study.
    Land SR
    J Clin Oncol; 2008 Nov; 26(31):5018-9. PubMed ID: 18809601
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of advanced non-small-cell lung cancer in patients with a performance status of 2.
    Lilenbaum R
    Clin Lung Cancer; 2004 Jan; 5(4):209-13. PubMed ID: 14967072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy in patients with advanced non-small cell lung cancer.
    Price A
    Clin Oncol (R Coll Radiol); 2001; 13(6):480-2. PubMed ID: 11824892
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of advanced non-small cell lung cancer.
    Shepherd FA
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):7-18. PubMed ID: 8091244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platinum-based chemotherapy for inoperable non-small cell lung cancer: a real therapeutic progress?
    Buccheri G
    Lung Cancer; 1994 Jul; 11(1-2):115-7. PubMed ID: 7521731
    [No Abstract]   [Full Text] [Related]  

  • 32. Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials.
    Gebbia V; Galetta D; De Marinis F
    Ann Oncol; 2005 May; 16 Suppl 4():iv123-131. PubMed ID: 15923412
    [No Abstract]   [Full Text] [Related]  

  • 33. Benefits of chemotherapy for quality of life in patients with advanced nonsmall-cell lung cancer.
    Paesmans M
    Curr Opin Oncol; 2002 Jul; 14(4):389-93. PubMed ID: 12130921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In chemotherapy for lung cancer, sometimes less is more.
    Roeland E; Loprinzi C; Moynihan TJ; Smith TJ; Temel J
    J Natl Compr Canc Netw; 2013 Mar; 11(3):232-5. PubMed ID: 23486449
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemotherapy and survival in non-small cell lung cancer. Three years later.
    Buccheri G
    Chest; 1994 Oct; 106(4):990-2. PubMed ID: 7924540
    [No Abstract]   [Full Text] [Related]  

  • 36. Potential hazards in the analysis of symptom improvement.
    Billingham L; Cullen M
    Lung Cancer; 2003 May; 40(2):201-2. PubMed ID: 12711122
    [No Abstract]   [Full Text] [Related]  

  • 37. 2003 highlights from: 10th World Congress on Lung Cancer.
    Tyagi F; Lee D
    Clin Lung Cancer; 2003 Sep; 5(2):78-82. PubMed ID: 14614760
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemotherapy for advanced non-small cell lung cancer.
    Thatcher N
    Lung Cancer; 2001 Dec; 34 Suppl 2():S171-5. PubMed ID: 11720761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: a meta-analysis.
    Des Guetz G; Uzzan B; Nicolas P; Valeyre D; Sebbane G; Morere JF
    Crit Rev Oncol Hematol; 2012 Dec; 84(3):340-9. PubMed ID: 22534083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of sex on efficacy, adverse events, quality of life, and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group non-small cell lung cancer chemotherapy trials.
    Wheatley-Price P; Le Maître A; Ding K; Leighl N; Hirsh V; Seymour L; Bezjak A; Shepherd FA;
    J Thorac Oncol; 2010 May; 5(5):640-8. PubMed ID: 20354457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.